SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DUSA (DUSA) Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?


To: DOLLAR BILL who wrote (84)11/23/1999 1:17:00 AM
From: ClearSky  Read Replies (1) | Respond to of 101
 
DB,

Murphy is also pushing CEPH, which has run up a bit lately, but he did raise his buy limit to around $20, I think. He has written up both CEPH and DUSA as being the most timely biotech purchases right now, with various news items expected on both by the end of January.

Looking forward to hearing about DUSA's partner deal.

Jeanne